Literature DB >> 2521185

Functions of the two adenovirus early E1A proteins and their conserved domains in cell cycle alteration, actin reorganization, and gene activation in rat cells.

A J Bellett1, P Jackson, E T David, E J Bennett, B Cronin.   

Abstract

Rat embryo cells were infected with adenovirus type 5 mutants that code for only one of the two early E1A proteins, mutants with defects in one of the two conserved regions common to the two proteins, or mutants with defects in the 46-amino-acid region unique to the 289-amino-acid E1A protein. Cells were scored for altered cell cycle progression, disruption of actin stress fibers, and activation of E2A expression. Mutants lacking either E1A protein were able to cause all of these effects; but mutants lacking a 243-amino-acid protein had less effect, and mutants lacking a 289-amino-acid protein much less effect, than wild-type virus. A mutation in any of the three conserved regions caused a defect in each E1A effect. To investigate the reported function of conserved domain 2 in mitosis, we monitored by fluorescence-activated cell sorter the reduction in Hoechst 33342 fluorescence that occurs when cells divide after undergoing a round of DNA replication in 5-bromodeoxyuridine. A smaller percentage of adenovirus-infected cells than mock-infected cells divided within a given period after completing a round of DNA replication. Viruses with mutations in conserved domain 2 were defective for initiation of cellular DNA replication, as were all other E1A mutants we have examined, but had no specific defect in cell division compared with wild-type virus. Thus, although there may be some specialization of function between the two E1A proteins and between their conserved domains, it was not apparent in the aspects of E1A function and the mutants that we examined.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2521185      PMCID: PMC247685     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Adenovirus E1a proteins repress transcription from the SV40 early promoter.

Authors:  A Velcich; E Ziff
Journal:  Cell       Date:  1985-03       Impact factor: 41.582

2.  Lytic and transforming functions of individual products of the adenovirus E1A gene.

Authors:  E Moran; T Grodzicker; R J Roberts; M B Mathews; B Zerler
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

3.  An adenovirus E1a protein region required for transformation and transcriptional repression.

Authors:  J W Lillie; M Green; M R Green
Journal:  Cell       Date:  1986-09-26       Impact factor: 41.582

4.  Mapping of functional domains in adenovirus E1A proteins.

Authors:  B Krippl; B Ferguson; N Jones; M Rosenberg; H Westphal
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

5.  An adenovirus early region 1A protein is required for maximal viral DNA replication in growth-arrested human cells.

Authors:  K R Spindler; C Y Eng; A J Berk
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

6.  Control functions of adenovirus transformation region E1A gene products in rat and human cells.

Authors:  A J Bellett; P Li; E T David; E J Mackey; A W Braithwaite; J R Cutt
Journal:  Mol Cell Biol       Date:  1985-08       Impact factor: 4.272

7.  Adenovirus 5 early region 1A host range mutants hr3, hr4, and hr5 contain point mutations which generate single amino acid substitutions.

Authors:  G M Glenn; R P Ricciardi
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

8.  Repression of the immunoglobulin heavy chain enhancer by the adenovirus-2 E1A products.

Authors:  R Hen; E Borrelli; P Chambon
Journal:  Science       Date:  1985-12-20       Impact factor: 47.728

9.  Induction of cellular DNA synthesis by purified adenovirus E1A proteins.

Authors:  L Kaczmarek; B Ferguson; M Rosenberg; R Baserga
Journal:  Virology       Date:  1986-07-15       Impact factor: 3.616

10.  The release of growth arrest by microinjection of adenovirus E1A DNA.

Authors:  S Stabel; P Argos; L Philipson
Journal:  EMBO J       Date:  1985-09       Impact factor: 11.598

View more
  10 in total

1.  A protein kinase is present in a complex with adenovirus E1A proteins.

Authors:  T Kleinberger; T Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

2.  Accumulation of p53 induced by the adenovirus E1A protein requires regions involved in the stimulation of DNA synthesis.

Authors:  E Querido; J G Teodoro; P E Branton
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

3.  The adenovirus E1A-associated kinase consists of cyclin E-p33cdk2 and cyclin A-p33cdk2.

Authors:  B Faha; E Harlow; E Lees
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

4.  Functional importance of complex formation between the retinoblastoma tumor suppressor family and adenovirus E1A proteins as determined by mutational analysis of E1A conserved region 2.

Authors:  H B Corbeil; P E Branton
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

Review 5.  Subversion of the actin cytoskeleton during viral infection.

Authors:  Matthew P Taylor; Orkide O Koyuncu; Lynn W Enquist
Journal:  Nat Rev Microbiol       Date:  2011-04-27       Impact factor: 60.633

6.  Differential requirement for adenovirus type 12 E1A gene products in oncogenic transformation.

Authors:  C Lamberti; J Williams
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

7.  Immortalization of primary epithelial cells requires first- and second-exon functions of adenovirus type 5 12S.

Authors:  M P Quinlan; J L Douglas
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

8.  The amino-terminal portion of CD1 of the adenovirus E1A proteins is required to induce susceptibility to tumor necrosis factor cytolysis in adenovirus-infected mouse cells.

Authors:  P J Duerksen-Hughes; T W Hermiston; W S Wold; L R Gooding
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

9.  Dedifferentiation by adenovirus E1A due to inactivation of Hippo pathway effectors YAP and TAZ.

Authors:  Nathan R Zemke; Dawei Gou; Arnold J Berk
Journal:  Genes Dev       Date:  2019-06-06       Impact factor: 11.361

Review 10.  Cancer Treatment Goes Viral: Using Viral Proteins to Induce Tumour-Specific Cell Death.

Authors:  Jasmine Wyatt; Manuel M Müller; Mahvash Tavassoli
Journal:  Cancers (Basel)       Date:  2019-12-07       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.